Replies to post #77258 on Biotech Values

[DewDiligence]

The NDA for LAR will evidently be a standard (10-month) rather than a priority review:

http://finance.yahoo.com/news/Exenatide-Once-Weekly-New-prnews-15131272.html

Comments?